share_log

Mangoceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jacob D. Cohen(34.7%),The Tiger Cub Trust(28.6%)

Mangoceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jacob D. Cohen(34.7%),The Tiger Cub Trust(28.6%)

Mangoceuticals | SC 13D/A：超過5%持股股東披露文件(修正)-Jacob D. Cohen(34.7%),The Tiger Cub Trust(28.6%)
美股SEC公告 ·  06/06 05:18

牛牛AI助理已提取核心訊息

On June 3, 2024, Mangoceuticals, Inc. experienced a significant event involving its stock ownership. Jacob D. Cohen, the company's CEO and Chairman, received an issuance of 800,000 fully-vested shares of common stock as a bonus for the year 2024. This decision was approved by the Board of Directors with the recommendation of the Compensation Committee. The Schedule 13D/A filing with the SEC, which is an amendment to the previous filings, reflects this change. As a result, Jacob D. Cohen now beneficially owns 10,575,000 shares, representing 34.7% of the company's common stock. Additionally, The Tiger Cub Trust, also a reporting person, holds 8,275,000 shares, which accounts for 28.6% of the common stock. These ownership percentages are based on 28,943,143 shares of common stock outstanding as of June 5, 2024. The filing confirms that no other person has the right to receive dividends or proceeds from the sale of the securities owned by the reporting persons.
On June 3, 2024, Mangoceuticals, Inc. experienced a significant event involving its stock ownership. Jacob D. Cohen, the company's CEO and Chairman, received an issuance of 800,000 fully-vested shares of common stock as a bonus for the year 2024. This decision was approved by the Board of Directors with the recommendation of the Compensation Committee. The Schedule 13D/A filing with the SEC, which is an amendment to the previous filings, reflects this change. As a result, Jacob D. Cohen now beneficially owns 10,575,000 shares, representing 34.7% of the company's common stock. Additionally, The Tiger Cub Trust, also a reporting person, holds 8,275,000 shares, which accounts for 28.6% of the common stock. These ownership percentages are based on 28,943,143 shares of common stock outstanding as of June 5, 2024. The filing confirms that no other person has the right to receive dividends or proceeds from the sale of the securities owned by the reporting persons.
2024年6月3日，Mangoceuticals公司的股權出現了重大事件。該公司的CEO兼董事長Jacob D.Cohen因2024年獲得80萬股已完全累積的普通股獎金。此決定獲得了董事會的批准，經由薪酬委員會的推薦。提交給證券交易委員會的13D/A通知書，這是對之前文件的修訂，並反映了這一變更。因此，Jacob D.Cohen現在持有10,575,000股普通股，佔公司普通股的34.7％。此外，Tiger Cub Trust也是一個申報人，持有8,275,000股股份，佔普通股的28.6％。這些所有權百分比基於截至2024年6月5日持有的28,943,143股普通股。提交的申報文件確認，沒有其他人有權從申報人名下持有的證券中獲得分紅或銷售收益。
2024年6月3日，Mangoceuticals公司的股權出現了重大事件。該公司的CEO兼董事長Jacob D.Cohen因2024年獲得80萬股已完全累積的普通股獎金。此決定獲得了董事會的批准，經由薪酬委員會的推薦。提交給證券交易委員會的13D/A通知書，這是對之前文件的修訂，並反映了這一變更。因此，Jacob D.Cohen現在持有10,575,000股普通股，佔公司普通股的34.7％。此外，Tiger Cub Trust也是一個申報人，持有8,275,000股股份，佔普通股的28.6％。這些所有權百分比基於截至2024年6月5日持有的28,943,143股普通股。提交的申報文件確認，沒有其他人有權從申報人名下持有的證券中獲得分紅或銷售收益。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間